Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
- 22 March 2018
- journal article
- review article
- Published by Taylor & Francis Ltd in Critical Reviews in Biochemistry and Molecular Biology
- Vol. 53 (3), 311-334
- https://doi.org/10.1080/10409238.2018.1458071
Abstract
Sirtuins are NAD(+)-dependent protein deacylases/ADP-ribosyltransferases that have emerged as candidate targets for new therapeutics to treat metabolic disorders and other diseases, including cancer. The sirtuin SIRT5 resides primarily in the mitochondrial matrix and catalyzes the removal of negatively charged lysine acyl modifications; succinyl, malonyl, and glutaryl groups. Evidence has now accumulated to document the roles of SIRT5 as a significant regulator of cellular homeostasis, in a context- and cell-type specific manner, as has been observed previously for other sirtuin family members. SIRT5 regulates protein substrates involved in glycolysis, the TCA cycle, fatty acid oxidation, electron transport chain, ketone body formation, nitrogenous waste management, and ROS detoxification, among other processes. SIRT5 plays pivotal roles in cardiac physiology and stress responses and is involved in the regulation of numerous aspects of myocardial energy metabolism. SIRT5 is implicated in neoplasia, as both a tumor promoter and suppressor in a context-specific manner, and may serve a protective function in the setting of neurodegenerative disorders. Here, we review the current understanding of functional impacts of SIRT5 on its metabolic targets, and its molecular functions in both normal and pathological conditions. Finally, we will discuss the potential utility of SIRT5 as a drug target and also summarize the current status, progress, and challenges in developing small molecule compounds to modulate SIRT5 activity with high potency and specificity.Keywords
Funding Information
- The Glenn Foundation for Medical Research
- the Melanoma Research Alliance
- The Harrington Discovery Institute
- AACR
- the University of Michigan Comprehensive Cancer Center
- The University of Michigan Cancer Research Committee
- NIH/NHLBI
- NIH/NIGMS
- NIH/NIA
This publication has 186 references indexed in Scilit:
- Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein KinaseMolecular Cell, 2012
- Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphismNeurobiology of Disease, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Post-ischemic activation of protein kinase C epsilon protects the hippocampus from cerebral ischemic injury via alterations in cerebral blood flowNeuroscience Letters, 2011
- Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseasesTrends in Pharmacological Sciences, 2010
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology & Medicine, 2010
- A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidationJournal of Inherited Metabolic Disease, 2010
- SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea CycleCell, 2009
- Structural Insights into Intermediate Steps in the Sir2 Deacetylation ReactionStructure, 2008
- ɛPKC phosphorylates the mitochondrial K+ATP channel during induction of ischemic preconditioning in the rat hippocampusBrain Research, 2007